Cite

HARVARD Citation

    Belic, J. et al. (2018). Genomic alterations in plasma DNA from patients with metastasized prostate cancer receiving abiraterone or enzalutamide. International journal of cancer. 143 (5), pp. 1236-1248. [Online]. 
  
Back to record